| 2023年年报 | 2022年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 医药流通(元) | 1,246,431,937.65 | 992,201,374.61 |
| 医药制造(元) | 906,207,612.91 | 946,984,216.00 |
| 营业成本(元) | ||
| 医药流通(元) | 874,108,345.44 | 623,491,357.22 |
| 医药制造(元) | 233,737,960.80 | 282,382,104.63 |
| 毛利(元) | ||
| 医药流通(元) | 372,323,592.21 | 368,710,017.39 |
| 医药制造(元) | 672,469,652.11 | 664,602,111.37 |
| 毛利率(%) | ||
| 医药流通(%) | 29.87 | 37.16 |
| 医药制造(%) | 74.21 | 70.18 |
| 收入构成(%) | ||
| 医药流通(%) | 57.90 | 51.17 |
| 医药制造(%) | 42.10 | 48.83 |
| 毛利构成(%) | ||
| 医药流通(%) | 35.64 | 35.68 |
| 医药制造(%) | 64.36 | 64.32 |